Physician profile
Jonathan P French
NPI 1831311679
$6,036.08
in general payments reported to CMS, 2019-2025
14 companies · $316 in 2025
The $316 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,540 · 2020: $665 · 2021: $563 · 2022: $830 · 2023: $511 · 2024: $612 · 2025: $316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,438.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,438.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $1,533.88 | 2019-2023 | Senza |
| Stryker Corporation | $910.36 | 2019 | |
| Spr Therapeutics, INC | $692.06 | 2020-2025 | Sprint Pns System |
| Medtronic USA, INC. | $646.03 | 2019 | |
| Abbott Laboratories | $573.91 | 2020-2025 | Eterna |
| Boston Scientific Corporation | $481.79 | 2019-2021 | |
| Vertos Medical, INC. | $465.14 | 2022-2024 | Mild Device Kit |
| Saluda Medical Americas, INC. | $335.20 | 2024 | Evoke |
| Avanos Medical | $170.70 | 2019-2024 | Standard Rf Disposables, Coolief* Cooled Radiofrequency |
| Relievant Medsystems, INC. | $106.37 | 2020-2021 | |
| Ibsa Pharma INC. | $56.51 | 2023-2024 | Tirosint, Licart, Tirosint |
| Curonix LLC | $25.22 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Nalu Medical, INC. | $23.92 | 2025 | Nalu Neurostimulation System |
| Inspire Medical Systems, INC. | $14.99 | 2023 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan French listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.